Insiders · Profile

Thornberry Nancy

Director at Denali Therapeutics · Director at Schrodinger. Filing since 11 Aug 2022. CIK 0001797826

Company
Date
Role
Action
Shares
Amount
Of holding
2 Sep 2026
Director
Sold on a plan
11,439
$261.93K
36.8%
22 May 2023
Director
Sold at will
14,850
$519.75K
100%
11 Aug 2022
Director
Sold, plan not stated
4,950
$173.25K
100%
3 decisions on file.